Status:
UNKNOWN
Performance Study of Targeted Sequencing Technology for VAP
Lead Sponsor:
The First Hospital of Jilin University
Conditions:
VAP - Ventilator Associated Pneumonia
Eligibility:
All Genders
Brief Summary
Main purpose: To evaluate the feasibility of tNGS for pathogen detection and drug resistance analysis in VAP patients. Research site and research population: This study is planned to be conducted in...
Detailed Description
The investigators plan to include 150 VAP patients in the ICU. Lower respiratory tract samples (BALF) from VAP patients were routinely tested and tNGS tested, and clinical information was collected. R...
Eligibility Criteria
Inclusion
- (1)VAP patients (2) Patients can collect the required test information
Exclusion
- (1) Clearly diagnosed as non-infectious patients
- (2) Insufficient samples or patients unwilling to participate
- (3) Life expectancy is less than 24 hours
- (4) Patients' clinical information cannot be obtained
Key Trial Info
Start Date :
October 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 30 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06035796
Start Date
October 1 2023
End Date
October 30 2025
Last Update
September 13 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.